Canaccord Genuity Maintains Buy on Braze, Lowers Price Target to $35

Benzinga Newsdesk www.benzinga.com Negative 70.1%

Neg 70.1% Neu 0% Pos 0%

Canaccord Genuity analyst David Hynes maintains Braze (NASDAQ:BRZE) with a Buy and lowers the price target from $40 to $35.